Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) (AIBL)
The study aimed to recruit and analyze 1000 individuals in Australia, including 200 with Alzheimer's disease (AD), 100 with mild cognitive impairment (MCI), and 700 cognitively healthy individuals. Healthy individuals included those with and without the ApoE ε4 allele, as well as those expressing subjective memory concerns. Recruitment targets were based on international cohort standards and ceased once each diagnostic group's specific target was met.
Study design
Cohort
Number of participants at first data collection
1,112 (participants)
Age at first data collection
Varied (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2006
Primary Institutions
University of Melbourne
Links
Profile paper DOI
Funders
National Health and Medical Research Council (NHMRC)
Alzheimer's Australia
Australian Research Council (ARC)
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Pfizer
Ongoing?
No
Data types collected
- Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
- Interview – face-to-face
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- None
- Magnetic Resonance Imaging (MRI)
- Positron Emission Tomography (PET)
- None
Engagement
Keywords
Consortia and dataset groups
